Filter posts

The New Road to IPO in the Age of the JOBS Act

Not surprisingly, sessions discussing the topic of IPOs at this year’s BIO Investor Forum, tend …

Biotech IPO Boom or Bubble? The Opening Plenary at the BIO Investor Forum

With 31 (and counting) life sciences companies having already placed IPOs on the market within …

Successful Public-Private Partnerships

According to BayBio, biomedical companies that can harness the power of patient groups will get …

BIO Investor Forum Kicks Off Amid Industry Optimism

Today, the BIO Investor Forum kicks off in San Francisco, Calif. BioWorld’s Catherine Shaffer paints …

BIO Investor Forum Interview with Regado Biosciences

BIO is very excited to be hosting the BIO Investor Forum next week in San …

BIO Investor Forum to Showcase NSF-funded Companies

No risk, no reward—that’s the concept driving the startups and entrepreneurs scheduled to present at …

New CDC Report on Alarming Rates of Antibiotic-Resistant Infections

Every year in the United States, 2 million people acquire an antibiotic-resistant infection. Of those, at …

BIO Investor Forum Company Snapshot: Opsona Therapeutics

Opsona Therapeutics will be participating in the upcoming BIO Investor Forum, and will be giving …

BIO Investor Forum Company Snapshot: Vaccinex

Recently, the CEO of Prosensa provided their company’s perspective participating in last year’s BIO Investor Forum. …

12th Annual BIO Investor Forum Presenting Companies Announced

Looking to lose a few pounds? Don’t want to diet or exercise? You’re not alone: …